Therefore, we analyzed how the A315T mutation in the TDP-43 protein could influence the NRF2 antioxidant signaling pathway in a transgenic mouse model for ALS at a symptomatic stage [33]. This evidence concerns the gene NFE2L2 and amyotrophic lateral sclerosis.